×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 2: Blood Pressure Changes Associated With New Drug Development - Regulatory and Scientific Updates
Session Chair(s)
Kentaro Ando, PhD
Department of Pharmacology
Toho University Faculty of Medicine, Japan
Yuji Kumagai, MD, PhD
Professor, Kitasato Clinical Research Center
Kitasato University Hospital, Japan
Speaker(s)
Off-Target Drug-induced Blood Pressure Changes: A Case Study
Rajanikanth Madabushi, PhD
FDA, United States
Associated Director for Guidance and Scientific Policy, OCP, OTS, CDER
Non-clinical Assessment of Blood Pressure Changes: Challenges, New Technologies and Translation to Human
Andrea Greiter-Wilke, DVM, PhD
F. Hoffmann-La Roche AG, Switzerland
Head, Safety Pharmacology
Off Target Blood Pressure Changes and Evaluation in Drug Development
Boaz Mendzelevski, MD
Cardiac Safety Consultants Ltd., United Kingdom
Consultant Cardiologist
Panel Discussion
All Session Speakers, United States
Have an account?